Skip to main content
. 2022 Nov 3;108(1):17–26. doi: 10.1159/000527223

Fig. 2.

Fig. 2

Bayesian network meta-analysis results for various randomized controlled studies describing the relative safety and incidence of serious adverse reactions in response to different biological agents during the treatment of lupus nephritis.